Manual Therapy and Movement Control Exercises for Chronic Neck Pain. A Pilot Randomized Controlled Trial
Unknown statusNot applicableNCT06189612
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Chronic neck pain is a common and highly prevalent clinical entity among the population. It causes a high economic and financial burden. Commonly people with neck pain present temporomandibular disorders (TMD). These conditions are closely correlated with each other. Several studies have shown that patients with neck pain do have abnormalities in motor control, endurance capacities, and strength of the cervical and orofacial area. Several treatment modalities are available for neck pain that can be divided into pharmaceutical and non-pharmaceutical approaches. Among the non-pharmaceutical interventions, physiotherapy, manual therapy and exercises are of interest. The effect of treatment modalities is heterogeneous. Passive modalities often lack positive long-term outcomes. Therefore, our trial aims to measure the effects of a combined treatment, consisting in manual therapy and a movement control training for the neck region or for the temporomandibular region, respectively. The implementation of the temporomandibular movement control training is based on the assumption that there might be crossover effects between both regions, i.e., convergence of cervical and trigeminal sensory afferents between these two regions. We designed a parallel randomized controlled trial (RCT) with three intervention arms and a blinded assessor for outcomes that are clinician performed. This study is a pilot trial, so each group is expected to consist of 15 subjects. Both female and male patients between the ages of 18 and 65 will be included. Participants must suffer from idiopathic chronic neck pain (at least 3 months) and may also have symptomatic TMD disorders. The Primary Outcome will be neck pain disability measured by the Neck Disability Index (NDI). Secondary Outcomes will be Diagnostic Criteria (DC)/TMD (Axis I and Axis II), range of motion (CROM, FRT), CVA, PPT, CCFT, and both cervical and orofacial test batteries to assess motor control in each region. Patients are randomly a…
Study details
- Official title
- Is the Combination of Manual Therapy and Movement Control Exercises More Effective Than Manual Therapy and Standard Exercises in a Population of Patients With Chronic Neck Pain to Reduce Neck Disability? A Pilot Randomized Controlled Trial
- Conditions
- Interventions
- Other: Clinical reasoning based physiotherapy + cervical movement control training
- Other: Clinical reasoning based physiotherapy + orofacial movement control training
- Other: Clinical reasoning based physiotherapy + standard exercises
- Sponsor
- Hochschule Osnabruck
- Collaborators
- Medizinische Gesellschaft für Myofasziale Schmerzen e.V.; Therapiecentrum Voxtrup - Praxis für Physiotherapie; Facharztzentrum für Orthopädie, Unfallchirurgie und Rehabilitation des Bewegungssystems
- Start date
- 2023-05-25
- Primary completion
- 2024-05-30
- Sex
- All
- Age range
- from 18 Years to 65 Years
- Healthy volunteers
- true
- Results posted
- No results posted in this snapshot
- Countries
- Germany
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * aged between 18 - 65 years of age * being diagnosed with idiopathic chronic neck pain (\>= 3 month) * scoring minimum \>= 15 in the NDI * linguistic (german) and cognitive ability to fully understand the questionnaires and exercise instructions. Exclusion Criteria: * presence of neurological symptoms of the upper limb * presence of elapsed fractures or surgeries in the past half year in the head, jaw or cervical region * medical interventions in these regions * systemic inflammatory conditions requiring systemic-acting drugs * Central Sensitization Index (CSI) score \> 40 points
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06189612